CNBC 快讯 6月22日 11:49 AbbVie斥资109亿美元收购Apogee：下一代免疫学并购潮的宏观交易解读 AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push AbbVie said on Monday it would buy biotech Apogee Therapeutics for $10.9 billion, in more than five years. FG 80 读报告 →